These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 19898197

  • 1. Re: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Uparkar M, Bhende M.
    Retina; 2009; 29(10):1549; author reply 1549-50. PubMed ID: 19898197
    [No Abstract] [Full Text] [Related]

  • 2. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M, Oddone F, Tedeschi M, Schiano Lomoriello D, Chiaravalloti A, Ripandelli G, Varano M.
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [Abstract] [Full Text] [Related]

  • 3. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results.
    Parravano M, Oddone F, Tedeschi M, Chiaravalloti A, Perillo L, Boccassini B, Varano M.
    Retina; 2010 Mar; 30(7):1017-24. PubMed ID: 20224469
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function.
    Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2376-83. PubMed ID: 19136707
    [Abstract] [Full Text] [Related]

  • 5. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C, Golbaz I, Stock G, Fous A, Kolar S, Pruente C, Schmidt-Erfurth U.
    Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
    [Abstract] [Full Text] [Related]

  • 6. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
    Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW, Esquiabro M.
    Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
    [Abstract] [Full Text] [Related]

  • 7. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA, Chang KT, Liakopoulos S, Jivrajka RV, Walsh AC, Sadda SR.
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 9. [Fundus-controlled microperimetry with the scanning laser ophthalmoscope in macular diseases].
    Schneider U, Kuck H, Inhoffen W, Kreissig I.
    Klin Monbl Augenheilkd; 1993 Sep; 203(3):212-8. PubMed ID: 8264213
    [Abstract] [Full Text] [Related]

  • 10. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 Sep; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 11. Visual outcome after intravitreal ranibizumab for wet age-related macular degeneration: a comparison between best-corrected visual acuity and microperimetry.
    Squirrell DM, Mawer NP, Mody CH, Brand CS.
    Retina; 2010 Mar; 30(3):436-42. PubMed ID: 19996834
    [Abstract] [Full Text] [Related]

  • 12. [The first experience of intravitreal injection of Lucentis (ranibizumab) in the moist form of age-related maculodystrophy].
    Baĭborodov IaV.
    Vestn Oftalmol; 2009 Mar; 125(5):31-3. PubMed ID: 19916331
    [Abstract] [Full Text] [Related]

  • 13. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.
    Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, Matsumoto Y, Sorenson JA, Yannuzzi L.
    Retina; 2008 Feb; 28(2):201-11. PubMed ID: 18301024
    [Abstract] [Full Text] [Related]

  • 14. Ranibizumab: Phase III clinical trial results.
    Rosenfeld PJ, Rich RM, Lalwani GA.
    Ophthalmol Clin North Am; 2006 Sep; 19(3):361-72. PubMed ID: 16935211
    [Abstract] [Full Text] [Related]

  • 15. Ranibizumab according to need: a treatment for age-related macular degeneration.
    Spaide R.
    Am J Ophthalmol; 2007 Apr; 143(4):679-80. PubMed ID: 17386275
    [No Abstract] [Full Text] [Related]

  • 16. Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy.
    Das R, Shi Y, Silvestri G, Chakravarthy U.
    Retina; 2009 Apr; 29(7):1013-8. PubMed ID: 19584658
    [Abstract] [Full Text] [Related]

  • 17. Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration.
    Ma Z, Han L, Wang C, Dou H, Hu Y, Feng X, Xu Y, Wang Z, Yin Z, Liu Y.
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2975-81. PubMed ID: 19117919
    [Abstract] [Full Text] [Related]

  • 18. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 19. Human neural retinal transplantation.
    Humayun MS, de Juan E, del Cerro M, Dagnelie G, Radner W, Sadda SR, del Cerro C.
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3100-6. PubMed ID: 10967070
    [Abstract] [Full Text] [Related]

  • 20. A comparison of macular translocation with patch graft in neovascular age-related macular degeneration.
    Chen FK, Patel PJ, Uppal GS, Rubin GS, Coffey PJ, Aylward GW, Da Cruz L.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1848-55. PubMed ID: 19060287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.